Not just bigwigs.. Mynvax joins race for COVID-19 vaccine
With vaccines of some firms already in animal trial phase, developers say that if all goes well, India could have a vaccine by next year
Not just bigwigs like Zydus and Serum but even mid-rung indigenous players across the country have joined the race for a coronavirus (Covid-19) vaccine. The move comes at a time when Chinese research firms are entering phase II of clinical trials in a global race to find a vaccine for Covid-19.
India, too, is gearing up to develop its indigenous variant soon. With vaccines of some firms already in animal trial phase, developers say that if all goes well, India could have a vaccine by next year.
So far, Indian companies that are in the race to make a vaccine include big players like Cadila Healthcare (Zydus Cadila), Serum Institute of India and Bharat Biotech as well as a start-up Mynvax, among others.
Now, joining the race are indigenous but mid-rung players like Gurugram-based IIT Bombay alumnus-led Premas Biotech, Ahmedabad-based animal vaccine player Hester Biosciences and pathlab start-up Neuberg Supratech.